1. Home
  2. Analysis
  3. Aricept
  4. Micronase

Aricept and Micronase drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aricept and Micronase. Common interactions include loss of consciousness among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people who take Aricept and Micronase have. It is created by eHealthMe based on reports of 14 people who take Aricept and Micronase from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 24, 2023

14 people who take Aricept and Micronase together, and have interactions are studied.

What is Aricept?

Aricept has active ingredients of donepezil hydrochloride. It is often used in alzheimer's disease. eHealthMe is studying from 23,863 Aricept users for its effectiveness, alternative drugs and more.

What is Micronase?

Micronase has active ingredients of glyburide. eHealthMe is studying from 1,915 Micronase users for its effectiveness, alternative drugs and more.

Number of Aricept and Micronase reports submitted per year:

Aricept and Micronase drug interactions.

Common Aricept and Micronase drug interactions by gender *:

female:

  1. Loss of consciousness
  2. Agitation
  3. Confusional state
  4. Gait abnormal
  5. Haemorrhage intracranial
  6. Mental disorder
  7. Nausea
  8. Pyrexia
  9. Rectal bleeding
  10. Renal failure acute

male:

  1. Abdominal pain
  2. Blindness
  3. Gastric ulcer
  4. Nausea
  5. Stomach discomfort
  6. Confusional state
  7. Hyperkalaemia
  8. Hypoglycaemia
  9. Lethargy
  10. Nasopharyngitis

Common Aricept and Micronase drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Pyrexia
  2. Abdominal pain
  3. Confusional state
  4. Escherichia infection
  5. Gastric ulcer
  6. Loss of consciousness
  7. Stomach discomfort
  8. Agitation
  9. Gait abnormal
  10. Haemorrhage intracranial

Common conditions people have *:

  1. Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 1 person, 7.14%
  2. Dementia (madness): 1 person, 7.14%
  3. Angiopathy (generic term for a disease of the blood vessels): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Aricept and Micronase?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Common Aricept and Micronase interactions:

Browse all drug interactions of Aricept and Micronase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Aricept side effects:

Browse all side effects of Aricept:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Micronase side effects:

Browse all side effects of Micronase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Aricept interactions:

Browse all interactions between Aricept and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Micronase interactions:

Browse all interactions between Micronase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on donepezil hydrochloride and glyburide (the active ingredients of Aricept and Micronase, respectively), and Aricept and Micronase (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Aricept and Micronase.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.